Why the Treatment of Mental Disorders Is an Important Component of HIV Prevention among People Who Inject Drugs

People who inject drugs are more likely to be HIV positive and to have a mental disorder than the general population. We explore how the detection and treatment of mental illness among people who are injecting drugs are essential to primary and secondary prevention of HIV infection in this populatio...

Full description

Bibliographic Details
Main Authors: Elizabeth Buckingham, Ezra Schrage, Francine Cournos
Format: Article
Language:English
Published: Hindawi Limited 2013-01-01
Series:Advances in Preventive Medicine
Online Access:http://dx.doi.org/10.1155/2013/690386
id doaj-f2b7d0aafa054af29044844dd5767f8d
record_format Article
spelling doaj-f2b7d0aafa054af29044844dd5767f8d2020-11-24T20:55:09ZengHindawi LimitedAdvances in Preventive Medicine2090-34802090-34992013-01-01201310.1155/2013/690386690386Why the Treatment of Mental Disorders Is an Important Component of HIV Prevention among People Who Inject DrugsElizabeth Buckingham0Ezra Schrage1Francine Cournos2Substance Abuse and Mental Health Services Administration, 1 Choke Cherry Road, Rockville, MD 20857, USASchool of General Studies, Columbia University, 2970 Broadway, New York, NY 10027, USAMailman School of Public Health, Columbia University, 722 W. 168th Street, New York, NY 10032, USAPeople who inject drugs are more likely to be HIV positive and to have a mental disorder than the general population. We explore how the detection and treatment of mental illness among people who are injecting drugs are essential to primary and secondary prevention of HIV infection in this population. Aside from opioid addiction, few studies have been conducted on the links between mental disorders and injection-drug use. However, independent of the injection-drug use literature, a growing number of studies demonstrate that untreated mental illness, especially depression and alcohol/substance use disorders, is associated with HIV-related risk behaviors, acquiring HIV infection, failure to access HIV care and treatment, failure to adhere to HIV care and treatment, and increased morbidity and mortality from HIV-related diseases and comorbidities. In our review of both the published literature and gray literature we found a dearth of information on models for providing care for both opioid addiction and other mental illnesses regardless of HIV status, particularly in low- and middle-income countries. We therefore make recommendations on how to address the mental health needs of HIV-positive people who inject drugs, which include the provision of opioid substitution therapy and integrated mental health, substance abuse, and HIV services.http://dx.doi.org/10.1155/2013/690386
collection DOAJ
language English
format Article
sources DOAJ
author Elizabeth Buckingham
Ezra Schrage
Francine Cournos
spellingShingle Elizabeth Buckingham
Ezra Schrage
Francine Cournos
Why the Treatment of Mental Disorders Is an Important Component of HIV Prevention among People Who Inject Drugs
Advances in Preventive Medicine
author_facet Elizabeth Buckingham
Ezra Schrage
Francine Cournos
author_sort Elizabeth Buckingham
title Why the Treatment of Mental Disorders Is an Important Component of HIV Prevention among People Who Inject Drugs
title_short Why the Treatment of Mental Disorders Is an Important Component of HIV Prevention among People Who Inject Drugs
title_full Why the Treatment of Mental Disorders Is an Important Component of HIV Prevention among People Who Inject Drugs
title_fullStr Why the Treatment of Mental Disorders Is an Important Component of HIV Prevention among People Who Inject Drugs
title_full_unstemmed Why the Treatment of Mental Disorders Is an Important Component of HIV Prevention among People Who Inject Drugs
title_sort why the treatment of mental disorders is an important component of hiv prevention among people who inject drugs
publisher Hindawi Limited
series Advances in Preventive Medicine
issn 2090-3480
2090-3499
publishDate 2013-01-01
description People who inject drugs are more likely to be HIV positive and to have a mental disorder than the general population. We explore how the detection and treatment of mental illness among people who are injecting drugs are essential to primary and secondary prevention of HIV infection in this population. Aside from opioid addiction, few studies have been conducted on the links between mental disorders and injection-drug use. However, independent of the injection-drug use literature, a growing number of studies demonstrate that untreated mental illness, especially depression and alcohol/substance use disorders, is associated with HIV-related risk behaviors, acquiring HIV infection, failure to access HIV care and treatment, failure to adhere to HIV care and treatment, and increased morbidity and mortality from HIV-related diseases and comorbidities. In our review of both the published literature and gray literature we found a dearth of information on models for providing care for both opioid addiction and other mental illnesses regardless of HIV status, particularly in low- and middle-income countries. We therefore make recommendations on how to address the mental health needs of HIV-positive people who inject drugs, which include the provision of opioid substitution therapy and integrated mental health, substance abuse, and HIV services.
url http://dx.doi.org/10.1155/2013/690386
work_keys_str_mv AT elizabethbuckingham whythetreatmentofmentaldisordersisanimportantcomponentofhivpreventionamongpeoplewhoinjectdrugs
AT ezraschrage whythetreatmentofmentaldisordersisanimportantcomponentofhivpreventionamongpeoplewhoinjectdrugs
AT francinecournos whythetreatmentofmentaldisordersisanimportantcomponentofhivpreventionamongpeoplewhoinjectdrugs
_version_ 1716792391240777728